BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Large Drop in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 141,300 shares, a decline of 32.2% from the February 28th total of 208,400 shares. Based on an average daily volume of 87,900 shares, the days-to-cover ratio is presently 1.6 days. Currently, 0.8% of the company’s stock are sold short.

BioStem Technologies Price Performance

Shares of BSEM stock opened at $9.13 on Friday. BioStem Technologies has a fifty-two week low of $6.77 and a fifty-two week high of $28.26. The stock’s 50-day moving average is $13.38 and its two-hundred day moving average is $13.83. The firm has a market cap of $152.51 million, a P/E ratio of 13.43 and a beta of -0.39.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.